No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleonly females |
293218 |
2. Check conditionsNone |
293218 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
316 |
4. Check minimum number of eventsNone |
316 |
5. Include endpointsNone |
316 |
6. Filter based on genotype QC (FinnGen only) |
305 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Endometroid carcinoma of ovary, including Hilmo
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of ovary, including Hilmo
- Malignant neoplasm, wide definition for exclusion
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 305 | 305 | - |
| Unadjusted period prevalence (%) | 0.11 | 0.11 | - |
| Median age at first event (years) | 59.33 | 59.33 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 316
- Matched controls
- 3160
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H02AB02
ATC
dexamethasone; systemic
180.5
307.7
169
20
C56.73
ICD-10 Finland
Endomeroid epithelial carcinoma of the ovary
+∞
307.7
273
*
8380/3-C56.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of ovary
+∞
264.1
215
*
A04AA01
ATC
ondansetron; systemic, rectal
63.8
230.9
136
37
128
Kela drug reimbursment
Cancers of female genital organs
+∞
217.8
183
*
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
56.7
194.7
116
32
A03FA01
ATC
metoclopramide; systemic, rectal
21.6
176.1
221
307
WX302
NOMESCO Finland
Thoracal epidural anesthesy
55.3
172.0
102
27
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
+∞
154.1
135
*
JEA00
NOMESCO Finland
Appendectomy
22.3
130.3
109
73
JN4BD
NOMESCO Finland
Extensive body CT
23.3
120.0
96
58
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
30.3
114.1
80
35
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
104.0
94
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
15.7
102.9
104
96
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
97.0
88
*
C56
ICD-10 Finland
Malignant neoplasm of ovary
+∞
97.0
88
*
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
20.4
93.9
78
50
B01AB10
ATC
tinzaparin; parenteral
12.1
92.6
115
143
JAL30
NOMESCO Finland
Omentectomy
205.4
89.4
89
6
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
+∞
81.9
75
*
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
15.5
74.4
71
58
JN4AD
NOMESCO Finland
Body CT examination
12.3
69.6
78
82
L03AA13
ATC
pegfilgrastim; parenteral
630.6
55.3
53
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
602.1
53.1
51
*
Z51.5
ICD-10 Finland
Palliative care
12.7
47.1
49
45
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
505.4
45.4
44
*
A04AA02
ATC
granisetron; systemic, transdermal
505.4
45.4
44
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
44.9
42
*
LCD00
NOMESCO Finland
Hysterectomy
8.3
44.7
66
97
TPH07
NOMESCO Finland
Cathetrisation of artery
6.7
43.7
82
156
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
42.7
40
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
42.7
40
*
L02BG04
ATC
letrozole; oral
86.8
41.1
45
6
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
40.5
38
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
14.8
39.8
37
28
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
11.0
39.5
45
47
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
39.4
37
*
JAH00
NOMESCO Finland
Laparotomy
15.6
38.8
35
25
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
5.2
37.1
97
248
A04AA03
ATC
tropisetron; systemic
388.1
35.7
35
*
L03AA02
ATC
filgrastim; parenteral
202.4
35.5
36
*
C56.98
ICD-10 Finland
Malignant tumor of the ovary, indeterminate histology
+∞
35.1
33
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
35.1
33
*
TLE20
NOMESCO Finland
Transvaginal puncture of cul-de-sac
371.2
33.6
33
*
Z31.5
ICD-10 Finland
Genetic counselling
9.9
33.5
41
47
B01AB05
ATC
enoxaparin; parenteral
4.0
32.9
166
686
HA1AA
NOMESCO Finland
X-ray mammography
8.1
32.3
47
67
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
3.9
32.0
172
738
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
31.8
30
*
ZXE20
NOMESCO Finland
More than three and less than five hours
5.0
31.6
82
206
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
30.7
29
*
1830A
ICD-9 Finland
Malignant neoplasm of ovary and other uterine adnexa, Ovary
+∞
29.6
28
*
130
Kela drug reimbursment
Malignant tumour
+∞
29.6
28
*
C56.79
ICD-10 Finland
Other epithelial carcinoma of the ovary
+∞
28.6
27
*
WW500
NOMESCO Finland
Blood transfusion
12.2
28.0
29
26
ZX120
NOMESCO Finland
Intravenous
6.5
27.4
49
87
WZC00
NOMESCO Finland
Treatment plan or consultation
3.6
27.4
143
589
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
26.4
25
*
JAL00
NOMESCO Finland
Biopsy of peritoneum
79.3
26.3
29
*
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
25.3
24
*
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
4.4
25.3
75
207
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.6
24.7
68
177
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
24.3
23
*
WX402
NOMESCO Finland
General anaesthesia
3.8
23.6
91
303
115
Kela drug reimbursment
Breast cancer
+∞
23.2
22
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
247.2
22.9
23
*
PJA12
NOMESCO Finland
Sentinel node biopsy
247.2
22.9
23
*
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
86.4
22.0
24
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
7.1
21.4
34
53
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
21.1
20
*
C56.72
ICD-10 Finland
Mucinous epithelial carcinoma of the ovary
+∞
21.1
20
*
L02BA01
ATC
tamoxifen; oral
+∞
21.1
20
*
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
4.0
20.9
70
210
N02AA05
ATC
oxycodone; systemic
3.5
20.1
85
298
PJD63
NOMESCO Finland
Laparoscopic dissection of aortic lymph nodes
+∞
20.0
19
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
112.1
19.8
21
*
X77
ICPC
Malignant neopl genital female other
+∞
18.9
18
*
JAL31
NOMESCO Finland
Laparoscopic omentectomy
+∞
18.9
18
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
18.9
18
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
18.9
18
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
201.5
18.7
19
*
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
6.4
18.3
32
55
JAH01
NOMESCO Finland
Laparoscopy
6.3
17.5
31
54
R18
ICD-10 Finland
Ascites
20.8
17.2
25
13
8461/3-C56.9
ICD-O-3
High grade serous carcinoma of ovary
+∞
16.8
16
*
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
29.4
16.7
22
8
D70.82
ICD-10 Finland
Drug-induced neutropenia
179.1
16.7
17
*
D39.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Female genital organ, unspecified
50.3
16.2
19
*
XX3DW
NOMESCO Finland
Time consuming IT work
5.0
16.1
37
82
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.1
16.1
87
350
C567, ,
ICD-10 Finland
+∞
15.8
15
*
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
+∞
15.8
15
*
WC115
NOMESCO Finland
Cytostatic therapy of local tumor recidive with multiple drugs
+∞
15.8
15
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
15.8
15
*
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
5.7
15.5
30
57
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
4.7
15.3
38
90
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
14.7
14
*
N80.1
ICD-10 Finland
Endometriosis of ovary
6.3
13.7
24
41
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
13.6
13
*
L02AB02
ATC
medroxyprogesterone; systemic
27.1
13.5
18
7
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
22.4
13.5
19
9
ZXE30
NOMESCO Finland
More than five and less than seven hours
6.0
13.1
24
43
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
29.8
13.1
17
6
ZXC40
NOMESCO Finland
Use of ultrasound
52.3
13.0
15
*
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
+∞
12.6
12
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
6.2
12.0
21
36
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
13.3
11.8
20
16
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
11.8
11.7
21
19
D39.19
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary with unspecified histology
24.0
11.7
16
7
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
8.9
11.5
24
29
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
11.5
11
*
8441/3-C56.9
ICD-O-3
Serous carcinoma, NOS, of ovary
+∞
11.5
11
*
C56.74
ICD-10 Finland
Mesonephroid epithelial carcinoma of the ovary
+∞
11.5
11
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
13.4
11.3
19
15
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.1
11.2
51
183
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
18.6
10.8
16
9
R2110
NOMESCO Finland
Giving the first information
3.6
10.6
37
112
A79
ICPC
Malignancy NOS
113.6
10.5
11
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
10.5
10
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
10.5
10
*
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
+∞
10.5
10
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
10.5
10
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
10.5
10
*
L01BC06
ATC
capecitabine; oral
+∞
10.5
10
*
B01AB04
ATC
dalteparin; parenteral
4.3
10.5
28
70
JFB46
NOMESCO Finland
Resection of sigmoid colon
16.8
10.5
16
10
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
16.8
10.5
16
10
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
19.6
10.4
15
8
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
27.0
9.9
13
5
HAB40
NOMESCO Finland
Wedge excision of mammary gland
20.8
9.9
14
7
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
103.0
9.5
10
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
9.4
9
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
9.4
9
*
L01CB01
ATC
etoposide; systemic
+∞
9.4
9
*
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
24.9
9.0
12
5
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
14.6
8.8
14
10
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
51.4
8.7
10
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
8.6
8.7
18
22
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
92.4
8.5
9
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
8.4
8
*
JAQ00
NOMESCO Finland
Extensive excision of peritoneum
+∞
8.4
8
*
18301
ICD-8 Finland
Malignant neoplasm of ovary, Fallopian tube and broad ligament, Ovary
+∞
8.4
8
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
8.4
8
*
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
+∞
8.4
8
*
8440/3-C56.9
ICD-O-3
Cystadenocarcinoma, NOS, of ovary
+∞
8.4
8
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
8.4
8
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.8
8.3
45
178
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
22.7
8.1
11
5
JN3AD
NOMESCO Finland
Abdominal CT examination
2.8
8.0
44
175
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
7.9
84
451
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
8.8
7.9
16
19
WX306
NOMESCO Finland
Lumbar epidural anesthesy
3.5
7.9
28
86
D39.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Uterus
46.1
7.7
9
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
46.1
7.7
9
*
I89.0
ICD-10 Finland
Lymphoedema, not elsewhere classified
18.9
7.7
11
6
WF002
NOMESCO Finland
Radical radiotherapy
25.7
7.6
10
*
JN4CD
NOMESCO Finland
Very extensive body CT
10.4
7.6
14
14
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.5
7.5
49
213
JAW96
NOMESCO Finland
Other operation on abdominal wall, peritoneum, mesentery or omentum
81.9
7.4
8
*
N02AX02
ATC
tramadol; systemic, rectal
1.9
7.4
152
1029
K56.7
ICD-10 Finland
Ileus, unspecified
9.7
7.4
14
15
Z85.4
ICD-10 Finland
Personal history of malignant neoplasm of genital organs
+∞
7.3
7
*
8205
FHL
Subradical ovarian malignancy removal (includes possible genital and omet removal)
+∞
7.3
7
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
7.3
7
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
7.3
7
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
7.3
7
*
L02BG03
ATC
anastrozole; oral
+∞
7.3
7
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
7.3
7
*
8102
FHL
Second look"" surgery for a malignant tumor
+∞
7.3
7
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
7.3
7
*
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.5
7.3
26
80
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.1
7.3
20
51
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
8.2
7.2
15
19
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.9
7.2
36
136
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
7.1
151
1031
R50.9
ICD-10 Finland
Fever, unspecified
2.5
7.1
48
212
N95.1
ICD-10 Finland
Menopausal and female climacteric states
0.2
6.8
7
322
JFF23
NOMESCO Finland
Transversostomy
41.0
6.8
8
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.9
6.6
32
119
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.8
6.5
34
132
TJA10
NOMESCO Finland
Laparocentesis
71.2
6.4
7
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
71.2
6.4
7
*
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
71.2
6.4
7
*
JFF10
NOMESCO Finland
Loop enterostomy
71.2
6.4
7
*
JFB00
NOMESCO Finland
Partial resection of small intestine
14.7
6.4
10
7
D39.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ovary
11.3
6.3
11
10
Z2446
NOMESCO Finland
Social worker
3.1
6.3
27
93
8140/3-C56.9
ICD-O-3
Adenocarcinoma, NOS, of ovary
+∞
6.3
6
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
6.3
6
*
JBA10
NOMESCO Finland
Transabdominal biopsy or excision of lesion of diaphragm
+∞
6.3
6
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
6.3
6
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
6.3
6
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
6.3
6
*
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
+∞
6.3
6
*
L02BG06
ATC
exemestane; oral
+∞
6.3
6
*
A04AD12
ATC
aprepitant; systemic
+∞
6.3
6
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
6.3
6
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.5
6.0
39
168
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
203
153
35.31
239.64
12.1
1.5
44.15
23.43
u/ml
1.13
197
148
104
79
19.13
115.81
1.9
1.5
211.44
59.28
pmol/l
4.07
99
79
118
146
12.30
95.58
3.2
1.4
4.04
2.66
ug/l
0.67
92
111
90
276
4.16
26.50
9.2
5.1
0.91
1.62
mmol/l
0.93
76
221
131
538
3.45
24.74
2.3
1.8
—
—
—
0
0
202
1090
3.37
23.98
5.2
3.4
34.02
35.67
g/l
3.76
195
1001
202
1116
3.25
22.52
2.8
2.1
—
—
—
0
0
36
65
6.12
19.63
3.0
1.9
35.17
14.18
u/ml
1.43
29
57
212
1276
3.01
19.00
9.4
3.2
10.19
10.46
umol/l
0.08
203
1184
217
1400
2.76
15.69
17.3
6.2
3.55
4.16
e9/l
5.32
187
1213
47
140
3.77
13.92
13.3
5.6
1.40
1.42
%
0.06
47
140
47
140
3.77
13.92
13.7
5.6
0.75
0.71
%
0.27
47
140
70
282
2.90
12.65
12.1
4.4
104.21
104.01
mmol/l
0.14
70
282
17
11
16.24
10.95
1.0
1.4
—
—
—
0
0
30
81
3.99
10.13
6.8
4.0
3.74
3.84
mmol/l
0.51
30
81
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
24
58
4.40
9.35
4.0
2.8
0.35
0.41
u/ml
—
10
43
178
1225
2.04
8.72
7.5
4.5
1.18
1.22
mmol/l
8.50
172
1088
172
1184
1.99
8.27
14.0
14.5
1.21
1.25
inr
0.19
42
344
235
2736
0.45
8.16
4.4
4.6
4.88
4.82
mmol/l
0.36
215
2502
244
2790
0.45
7.54
4.9
5.2
2.82
2.80
mmol/l
0.08
221
2542
250
2002
2.19
7.50
10.3
5.0
81.34
75.35
u/l
2.23
235
1827
16
22
7.60
7.28
1.0
2.1
3.56
170.78
u/ml
0.48
16
22
235
2714
0.48
7.08
4.2
4.6
1.64
1.60
mmol/l
0.63
211
2475
239
2738
0.48
6.79
4.6
4.8
5.88
5.92
mmol/l
0.16
217
2477
184
1353
1.86
6.70
7.8
5.0
1.18
1.23
mmol/l
9.12
171
1160
41
174
2.56
6.54
5.4
4.2
7.42
10.09
mmol/l
2.23
41
160
95
573
1.94
6.37
1.9
1.6
1.56
1.00
mg/l
1.92
80
445
230
2645
0.52
5.83
5.0
5.4
1.80
2.36
mu/l
0.64
210
2419
224
2585
0.54
5.42
5.6
6.0
39.85
39.93
mmol/mol
0.04
200
2384
184
1409
1.73
5.33
4.9
4.0
0.00
0.01
estimate
0.50
24
242
50
254
2.15
5.30
2.4
2.0
4.18
5.20
umol/l
1.87
44
214
182
1399
1.71
5.12
7.1
5.5
0.00
0.00
estimate
-0.00
23
235
37
174
2.28
4.73
1.4
1.5
—
—
—
0
0
126
907
1.65
4.34
3.4
3.1
—
—
—
0
0
44
233
2.03
4.18
3.4
2.8
2.97
2.49
mmol/l
0.30
38
200
197
2307
0.61
4.13
4.2
4.4
14.81
14.92
pmol/l
0.26
175
2105
189
1516
1.61
4.11
7.2
3.9
6.80
6.65
mmol/l
0.57
183
1400
232
2609
0.58
4.08
3.8
4.1
1.30
1.25
mmol/l
0.56
204
2348
67
434
1.69
3.37
2.6
2.7
1.74
1.73
e6/l
0.00
32
243
124
934
1.54
3.34
4.9
2.1
2.36
2.36
mmol/l
0.10
113
779
98
701
1.58
3.31
2.8
3.1
0.36
0.49
e6/l
0.44
69
543
26
124
2.20
3.24
13.0
4.8
24.62
25.77
mmol/l
1.01
26
124
7
11
6.48
3.20
1.4
1.0
238.29
320.00
u/l
—
7
11
81
563
1.59
3.07
1.3
1.3
—
—
—
0
0
18
379
0.44
2.96
3.8
4.8
28.00
34.00
%
—
9
237
279
2950
0.54
2.90
36.7
18.4
4.17
4.40
e12/l
12.06
270
2844
7
13
5.48
2.88
1.3
1.5
—
—
—
0
0
279
2949
0.54
2.86
36.7
18.4
263.61
261.49
e9/l
0.22
272
2851
279
2949
0.54
2.86
37.7
18.3
36.93
39.37
%
9.78
262
2709
40
238
1.78
2.71
1.7
2.1
27.13
35.36
u/l
0.85
32
191
109
830
1.48
2.68
2.8
2.1
86.74
56.80
u/l
0.50
101
746
15
62
2.49
2.58
2.9
3.2
—
—
—
0
0
10
32
3.19
2.45
1.0
1.3
—
—
—
0
0
26
139
1.95
2.45
1.7
1.5
—
—
—
0
0
57
386
1.58
2.39
2.6
2.9
3.30
4.94
e6/l
0.70
24
193
9
28
3.28
2.32
1.3
1.2
—
—
—
0
0
101
1269
0.70
2.27
2.4
2.3
82.88
80.55
nmol/l
0.30
90
1106
42
628
0.62
2.23
1.2
1.3
0.56
2.46
u/ml
—
8
163
8
24
3.39
2.19
1.4
1.2
—
—
—
0
0
9
30
3.06
2.16
1.0
1.4
—
—
—
0
0
24
131
1.90
2.15
4.0
2.0
0.60
0.67
%
0.57
24
131
24
134
1.86
2.02
4.0
2.0
1.30
1.19
%
0.28
24
134
67
887
0.69
1.96
2.0
2.0
99.02
153.43
u/l
1.40
59
837
5
11
4.60
1.95
1.4
1.2
—
—
—
0
0
5
11
4.60
1.95
1.4
1.2
—
—
—
0
0
16
79
2.08
1.89
1.4
1.4
—
—
—
0
0
9
34
2.69
1.88
1.3
1.2
—
—
—
0
0
188
2099
0.74
1.80
4.1
4.4
16.48
12.81
mm/h
2.13
168
1913
5
13
3.89
1.72
1.4
1.2
—
—
—
0
0
37
533
0.65
1.65
1.3
1.3
45.26
13.56
u/ml
0.46
11
191
161
1394
1.32
1.64
5.3
4.0
0.00
0.01
estimate
0.50
28
263
27
169
1.65
1.58
4.1
2.9
4.40
4.49
pmol/l
0.22
27
144
44
310
1.49
1.56
2.9
2.4
23.11
21.72
%
0.24
39
260
40
284
1.47
1.38
1.7
1.8
—
—
—
0
0
6
23
2.64
1.37
1.3
1.1
—
—
—
0
0
39
285
1.42
1.18
1.8
1.8
—
—
—
0
0
0
34
0.00
1.16
0.0
1.1
—
—
—
0
0
31
430
0.69
1.15
1.4
1.5
—
—
—
0
0
52
401
1.36
1.15
1.7
1.7
—
—
—
0
0
5
22
2.29
1.03
2.8
2.1
—
—
—
0
0
7
34
2.08
1.03
1.0
1.2
—
—
—
0
0
9
48
1.90
1.01
1.0
1.4
—
—
—
0
0
9
48
1.90
1.01
1.0
1.4
—
—
—
0
0
0
31
0.00
0.97
0.0
1.1
—
103.57
—
0
7
136
1515
0.82
0.97
2.5
2.7
—
—
—
0
0
104
1190
0.81
0.96
3.1
2.7
114.21
89.93
ug/l
0.68
96
1081
11
62
1.80
0.95
1.3
1.4
—
—
—
0
0
11
62
1.80
0.95
1.5
1.5
—
—
—
0
0
17
253
0.65
0.92
3.1
3.1
85.29
75.82
ng/l
0.32
17
220
30
220
1.40
0.91
2.7
2.0
50.76
66.06
ml/min/173m2
1.89
17
86
64
527
1.27
0.90
4.6
4.2
22.75
122.48
ng/l
2.89
51
414
277
2860
0.75
0.90
17.5
8.9
23.68
22.57
u/l
0.61
271
2730
8
43
1.88
0.88
1.3
1.2
—
—
—
0
0
108
1218
0.83
0.84
2.2
2.1
81.99
98.73
pmol/l
2.51
50
551
78
908
0.81
0.84
3.4
3.5
13.35
6.74
mg/mmol
0.62
45
511
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
5
100
0.49
0.78
1.2
1.3
—
25.20
—
0
6
49
595
0.79
0.77
1.4
1.7
1328.70
1216.18
nmol/l
0.32
37
430
276
2843
0.77
0.77
29.8
14.1
71.14
70.98
umol/l
0.04
276
2843
6
34
1.78
0.76
1.3
1.1
—
—
—
0
0
66
774
0.81
0.76
1.8
1.6
1.56
1.32
mmol/l
1.09
56
656
5
27
1.87
0.68
1.0
1.1
—
—
—
0
0
116
1048
1.17
0.65
4.5
3.6
29.74
61.88
ng/l
0.46
87
724
274
2654
1.24
0.63
20.3
12.2
34.55
20.40
mg/l
8.02
247
2031
9
141
0.63
0.61
1.0
1.6
—
—
—
0
0
8
52
1.55
0.60
1.0
1.1
—
—
—
0
0
6
37
1.63
0.56
1.5
1.2
—
—
—
0
0
46
540
0.83
0.54
1.2
1.3
18.40
40.93
iu/ml
—
10
178
6
38
1.59
0.54
1.5
1.3
—
—
—
0
0
16
211
0.75
0.49
1.3
1.2
140.33
122.18
iu/ml
—
9
91
7
46
1.53
0.48
1.3
1.2
—
—
—
0
0
7
47
1.50
0.48
1.4
1.5
—
—
—
0
0
5
85
0.58
0.46
1.0
1.7
—
—
—
0
0
5
32
1.57
0.42
1.2
1.2
—
—
—
0
0
57
640
0.87
0.41
1.5
1.7
1266.15
11928902.04
pmol/l
0.50
41
503
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.6
—
26.80
—
0
5
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
17
0.00
0.41
0.0
1.8
—
—
—
0
0
0
17
0.00
0.41
0.0
1.8
—
—
—
0
0
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
65
720
0.88
0.39
1.7
1.5
24.39
22.35
nmol/l
0.51
57
597
130
1221
1.11
0.38
5.4
5.3
25.71
28.54
%
2.34
122
1127
44
385
1.17
0.38
12.7
6.6
—
—
—
0
0
6
41
1.47
0.36
1.2
1.4
—
—
—
0
0
5
76
0.65
0.36
1.2
1.3
—
48.56
—
0
10
18
145
1.26
0.34
1.3
1.7
—
—
—
0
0
29
247
1.19
0.34
2.5
3.4
—
—
—
0
0
60
544
1.13
0.32
3.0
2.2
2.48
2.45
mmol/l
1.09
54
470
91
846
1.11
0.32
3.3
2.7
1843.43
1235.09
ng/l
0.37
81
701
7
54
1.30
0.30
1.0
1.1
—
—
—
0
0
114
1076
1.09
0.29
5.1
4.2
—
—
—
0
0
127
1212
1.08
0.25
5.3
5.1
59.20
57.15
%
1.17
118
1117
79
740
1.09
0.24
5.1
4.3
0.04
0.00
estimate
0.48
23
243
6
84
0.71
0.24
1.3
1.4
0.00
0.00
g/l
—
6
78
13
106
1.24
0.23
1.5
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
0.63
—
0
5
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
10.35
—
0
13
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
6
48
1.25
0.20
2.0
3.2
57.00
60.52
%
—
6
48
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
10
81
1.24
0.19
1.5
1.4
—
—
—
0
0
72
683
1.07
0.17
2.2
2.2
3.42
3.15
mg/l
0.25
59
565
26
235
1.12
0.16
4.6
3.5
108.86
228.14
ng/l
1.39
21
215
8
72
1.11
0.16
1.4
1.4
—
—
—
0
0
6
77
0.78
0.16
1.0
1.2
—
—
—
0
0
6
78
0.76
0.15
4.3
1.5
—
1.21
—
0
9
17
192
0.88
0.15
2.4
1.8
—
—
—
0
0
9
109
0.82
0.13
1.0
1.3
—
—
—
0
0
278
2802
0.93
0.11
27.5
14.8
3.93
3.95
mmol/l
0.86
272
2711
10
86
1.17
0.11
1.5
1.5
—
—
—
0
0
10
114
0.87
0.09
1.3
1.4
—
—
—
0
0
278
2798
0.95
0.08
28.1
14.6
139.32
139.78
mmol/l
2.33
272
2713
8
90
0.89
0.07
1.1
1.6
—
120.00
—
0
5
9
100
0.90
0.06
1.1
1.2
—
—
—
0
0
9
100
0.90
0.06
1.1
1.2
—
—
—
0
0
62
632
0.98
0.03
1.9
2.0
8696.53
7193.77
umol/l
0.06
53
540
15
158
0.95
0.02
1.1
1.7
—
—
—
0
0
163
1640
0.99
0.02
3.8
2.8
52.23
38.92
u/l
1.60
147
1496
14
146
0.96
0.00
1.1
1.4
—
—
—
0
0
13
132
0.98
0.00
1.0
1.1
—
—
—
0
0
253
2535
0.99
0.00
21.2
11.3
76.13
76.83
ml/min/173m2
0.21
221
2029
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
1.70
—
0
6
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
111.83
—
0
6
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
7
73
0.96
-0.00
1.0
1.1
—
16.72
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
21.72
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
111.00
—
0
5
8
85
0.94
-0.00
2.3
1.8
117.75
329.92
ug/l
—
8
76
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.2
—
—
—
0
0
5
55
0.91
-0.00
1.4
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
53
0.94
-0.00
3.2
3.0
27.76
26.15
mmol/l
—
5
53
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
5
56
0.89
-0.00
1.0
1.2
0.74
0.64
nmol/l
—
5
51
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
53
0.94
-0.00
1.0
1.3
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
189.42
—
0
8
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_OVARY_ENDOMETROID_WIDE – Endometroid carcinoma of ovary, including Hilmo
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).